S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ALLR Allarity Therapeutics Inc

1.09

0.035 (3.32%)

Pre Market

Last Updated: 23:00:05

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics (NASDAQ:ALLR)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Allarity Therapeutics Charts.

Allarity Therapeutics Inc News

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC
Friday 31 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 30 January 2025 (6 days ago) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Saturday 25 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
Tuesday 19 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Allarity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Recent Operational Highlights
Friday 15 November 2024 (3 months ago) • GlobeNewswire Inc.

More Allarity Therapeutics Inc News Articles

BNP Paribas Issuance

Societe Generale Effekten

Global Connectivity

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions